Abiopharma

New Form 10-Q - FibroBiologics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100917 Size: 8 MB

New Form 8-K - BIO-RAD LABORATORIES, INC. Filed: 2025-07-31 AccNo: 0000012208-25-000051 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100918 Size: 154 KB Item 8.01: Other Events

Bio-Rad - Bio-Rad Reports Second-Quarter 2025 Financial Results

Eastman Chemical Company - Eastman Announces Second-Quarter 2025 Financial Results

New Form 4 - DBV Technologies S.A. Filed: 2025-07-31 AccNo: 0001415889-25-020722 Size: 5 KB

BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Bio-Rad Reports Second-Quarter 2025 Financial Results

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

New Form 10-Q - OPKO HEALTH, INC. Filed: 2025-07-31 AccNo: 0000950170-25-100908 Size: 18 MB

New Form 8-K - STRYKER CORP Filed: 2025-07-31 AccNo: 0000310764-25-000103 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Envista Holdings Corp Filed: 2025-07-31 AccNo: 0001757073-25-000042 Size: 720 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Safety Shot, Inc. Filed: 2025-07-31 AccNo: 0001641172-25-021736 Size: 270 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - ILLUMINA, INC. Filed: 2025-07-31 AccNo: 0001110803-25-000057 Size: 841 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits